John E. Bishop - Feb 28, 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role: SVP, Chief Technology Officer
Signature: /s/ Jeannette Potts, as Attorney-in-Fact
Stock symbol: FMTX
Transactions as of: Feb 28, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/2/2022, 04:14 PM
Previous filing: Jun 15, 2021
Next filing: Oct 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FMTX	Common Stock	Award	$0	+26K	+117.95%	$0.00	48K	Feb 28, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FMTX	Stock Option (Right to Buy)	Award	$0	+38.9K		$0.00	38.9K	Feb 28, 2022	Common Stock	38.9K	$9.86	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2	25% of the shares subject to the stock option shall vest on February 28, 2023, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.